Open Access<p>Synergistic Effect Of A Retinoid X Receptor-Selective Ligand Bexarotene And Docetaxel In Prostate Cancer [Corrigendum]</p>
Author(s) -
Danyang Shen,
Huan Wang,
Qiming Zheng,
Sheng Cheng,
Liwei Xu,
Tong Wang,
Gonghui Li,
Liqun Xia
Publication year - 2019
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s235000
Subject(s) - bexarotene , docetaxel , prostate cancer , retinoid x receptor , medicine , cancer research , ligand (biochemistry) , pharmacology , retinoid , oncology , cancer , receptor , chemistry , nuclear receptor , biochemistry , transcription factor , retinoic acid , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom